St. Jude researchers developed a powerful tool that can identify cancer-causing mutations in genomes.
St. Jude scientists create more scalable tools to study genome-editing methods.
Recent research shows how an overactive immune system produces too many cytokines in HLH.
St. Jude scientists are studying the effect of cancer treatments and inherited mutations in DNA-repair genes.
Beyond its role in cell death,
St. Jude scientists have uncovered how caspase-8 contributes to inflammation.
St. Jude contribute to a study of bacteria and its evolving resistance to antibiotics.
St. Jude researchers contribute to studying the nucleolus to learn more about phase separation.
Studying the interactions between proteins and RNA which define phase separation,
St. Jude researchers were able to determine how each protein contributes.
St. Jude researchers discovered possible new ways to fight viruses and inflammatory illnesses.
A new anti-malarial drug offers hope for children suffering from Malaria.
Researchers find connections to inherited genetic mutations to a type of brain tumor. The study suggests certain genes should be included in routine testing.
St. Jude are studying the role oxygen plays in the maturation and migration of neurons and have identified a new mechanism that helps control these processes.
St. Jude Children’s Research Hospital scientists developed a way to discover the genes responsible for resistance to steroids in leukemia patients.
New research suggests that obesity may be linked to increased severity and longer duration of the flu as well as higher amounts of flu in the body.
St. Jude has developed a way to predict how proteins phase separate. The answer will help scientists studying how these proteins contribute to disease.
Results show a gene that drives cancer by promoting alternative polyadenylation
St. Jude is working with the Chinese Children’s Cancer Group to lead the first Phase III clinical trial comparing targeted therapies for a high-risk type of leukemia.